The Filing Desk

Stevanato Group S.p.A. vs Tandem Diabetes Care

Stevanato Group S.p.A. STVN · Tandem Diabetes Care TNDM · Health Care Equipment

Stevanato Group S.p.A. reported revenue of €1.2 billion in fiscal 2025, and Tandem Diabetes Care $1.0 billion in fiscal 2025, in different currencies. Stevanato Group S.p.A.'s revenue grew 7.5% in its latest year, and Tandem Diabetes Care's grew 7.9%. Stevanato Group S.p.A. had an operating margin of 16.8%, against -18.4% at Tandem Diabetes Care. Free cash flow was €22 million at Stevanato Group S.p.A. and −$30 million at Tandem Diabetes Care.

Side by side

Stevanato Group S.p.A.Tandem Diabetes Care
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue€1.2B$1.0B
Revenue growth7.5%7.9%
Revenue growth a year, last 5 years12.4%15.3%
Gross margin29.0%53.8%
Operating margin16.8%−18.4%
Net margin11.8%−20.2%
Free cash flow€22M−$30M
Free cash flow margin1.9%−2.9%
Return on capital8.3%−85.5%
Net debt to EBITDA——
Dividends and buybacks€15M$0M
Change in diluted share count0.7%2.8%
Last close$15.93$16.80
P/E at the last close——
Insider trades, last 12 monthssold $485,254sold $36,911
Piotroski F-score6 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
In each company's own currency, fiscal years
Stevanato Group S.p.A.Tandem Diabetes Care
Operating margin
Percent of revenue
Stevanato Group S.p.A.Tandem Diabetes Care
Free cash flow
In each company's own currency. Cash from operations minus capital expenditure.
Stevanato Group S.p.A.Tandem Diabetes Care

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Stevanato Group S.p.A. and Tandem Diabetes Care pages.